Metraipolis › archive › dc_c281031041eb

IL 15 enhances preclinical efficacy of anti-core 1 O-glycans monoclonal antibody NEO-201 against human endometrial and ovarian cancer — Europe PMC PMID:41816338

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41816338
DOI
10.3389/fimmu.2026.1652596
License (as archived)
solo-consultazione
Archived
2026-11-05T12:59:30.306Z
SHA-256 of the archived text
ee1aa8d5767f5ef6f4e533be3a595e3d2cc4b239e37af41fa06c2671682eaa0a
Stable URL of this page
https://metraipolis.com/documento/dc_c281031041eb

How to cite

IL 15 enhances preclinical efficacy of anti-core 1 O-glycans monoclonal antibody NEO-201 against human endometrial and ovarian cancer — Europe PMC PMID:41816338 — Europe PMC (en), https://europepmc.org/article/MED/41816338 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c281031041eb (Metraipolis archive dc_c281031041eb, sha256 ee1aa8d5767f5ef6f4e533be3a595e3d2cc4b239e37af41fa06c2671682eaa0a)
BibTeX
@misc{dcc281031041eb,
  title = {IL 15 enhances preclinical efficacy of anti-core 1 O-glycans monoclonal antibody NEO-201 against human endometrial and ovarian cancer — Europe PMC PMID:41816338},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41816338},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c281031041eb; sha256 ee1aa8d5767f5ef6f4e533be3a595e3d2cc4b239e37af41fa06c2671682eaa0a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41816338. Agents can read the archived copy with the MCP tool read_document.